This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoshioka, K. Articles by Itoh, K. Search for Related Content PubMed PubMed Citation Articles by Yoshioka, K. Articles by Itoh, K.

Overexpression of Small GTP-binding Protein RhoA Promotes Invasion of Tumor Cells¹

Department of Tumor Biology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511 [K. Y., K. I.]; and Department of Surgery II, Osaka University Medical School, Suita, Osaka 565-0871 [S. N.], Japan

Adhesion of tumor cells to host cell layers and subsequent migration are pivotal steps in cancer invasion and metastasis. The small GTP-binding protein RhoA controls cell adhesion and motility through organization of the actin cytoskeleton and regulation of actomyosin contractility. Cultured rat MM1 hepatoma cells migrate through a mesothelial cell monolayer in vitro in a serum-dependent, RhoA-mediated manner (K. Yoshioka et al., J. Biol. Chem., 273: 5146–5154, 1998). Furthermore, the ROCK family of RhoA-associated serine-threonine protein kinases is involved in this migration, and an inhibitor for these kinases effectively inhibits the invasion of MM1 cells in vitro and in vivo (K. Itoh et al., Nat. Med., 5: 221–225, 1999). Although there have been no reports of genetic alterations directly affecting RhoA in human cancer, the expression level of RhoA in tumors has been several times higher than that of surrounding normal tissue; RhoA was especially highly expressed in the metastatic region. To determine whether RhoA is activated by its overexpression, we made stable transfectants of MM1 cells expressing various levels of wild-type human RhoA. These transfectants showed promoted invasive ability in vitro in the absence and presence of 1-oleoyl-lysophosphatidic acid, marked adherence to the plastic culture dish with scattered shape, elevated phosphorylation of M_r 20,000 myosin light chain, and translocation of RhoA protein from the cytosol to the membrane. All of these phenotypes were similar to those of active RhoA transfectants, correlated with the expression level of RhoA and reversed by the treatment of the cells with Clostridium botulinum exoenzyme C3 ADP-ribosyltransferase. In addition, overexpression of wild-type RhoA in MM1 cells also conferred invasive ability in vivo after the cells were transplanted into the syngeneic rats. Thus, high expression of RhoA in the cell facilitates the translocation of this protein to the membrane, where it is activated, resulting in the stimulation of the RhoA-ROCK-actomyosin system, leading to invasion.

This article has been cited by other articles:

				M. C. Garcia, D. M. Ray, B. Lackford, M. Rubino, K. Olden, and J. D. Roberts Arachidonic Acid Stimulates Cell Adhesion through a Novel p38 MAPK-RhoA Signaling Pathway That Involves Heat Shock Protein 27 J. Biol. Chem., July 31, 2009; 284(31): 20936 - 20945. [Abstract] [Full Text] [PDF]

				S. Zhang, Q. Tang, F. Xu, Y. Xue, Z. Zhen, Y. Deng, M. Liu, J. Chen, S. Liu, M. Qiu, et al. RhoA Regulates G1-S Progression of Gastric Cancer Cells by Modulation of Multiple INK4 Family Tumor Suppressors Mol. Cancer Res., April 1, 2009; 7(4): 570 - 580. [Abstract] [Full Text] [PDF]

				C. Laezza, S. Pisanti, A. M. Malfitano, and M. Bifulco The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway Endocr. Relat. Cancer, December 1, 2008; 15(4): 965 - 974. [Abstract] [Full Text] [PDF]

				N. Kakinuma, B. C. Roy, Y. Zhu, Y. Wang, and R. Kiyama Kank regulates RhoA-dependent formation of actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling J. Cell Biol., October 14, 2008; 181(3): 537 - 549. [Abstract] [Full Text] [PDF]

				P. R. Molli, L. Adam, and R. Kumar Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase Clin. Cancer Res., October 1, 2008; 14(19): 6161 - 6170. [Abstract] [Full Text] [PDF]

				M. Iiizumi, S. Bandyopadhyay, S. K. Pai, M. Watabe, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, K. Saito, E. Furuta, et al. RhoC Promotes Metastasis via Activation of the Pyk2 Pathway in Prostate Cancer Cancer Res., September 15, 2008; 68(18): 7613 - 7620. [Abstract] [Full Text] [PDF]

				Y.-C. Lin, J.-H. Lin, C.-W. Chou, Y.-F. Chang, S.-H. Yeh, and C.-C. Chen Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2 Cancer Res., April 1, 2008; 68(7): 2375 - 2383. [Abstract] [Full Text] [PDF]

				T. K. Lee, R. T.P. Poon, J. Y. Wo, S. Ma, X.-Y. Guan, J. N. Myers, P. Altevogt, and A. P.W. Yuen Lupeol Suppresses Cisplatin-Induced Nuclear Factor-{kappa}B Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model Cancer Res., September 15, 2007; 67(18): 8800 - 8809. [Abstract] [Full Text] [PDF]

				J. Huang, Z. D. Liang, T.-T. Wu, A. Hoque, H. Chen, Y. Jiang, H. Zhang, and X.-c. Xu Tumor-Suppressive Effect of Retinoid Receptor-Induced Gene-1 (RRIG1) in Esophageal Cancer Cancer Res., February 15, 2007; 67(4): 1589 - 1593. [Abstract] [Full Text] [PDF]

				Z. D. Liang, S. M. Lippman, T.-T. Wu, R. Lotan, and X.-C. Xu RRIG1 Mediates Effects of Retinoic Acid Receptor {beta}2 on Tumor Cell Growth and Gene Expression through Binding to and Inhibition of RhoA. Cancer Res., July 15, 2006; 66(14): 7111 - 7118. [Abstract] [Full Text] [PDF]

				L. Y. W. Bourguignon, E. Gilad, A. Brightman, F. Diedrich, and P. Singleton Hyaluronan-CD44 Interaction with Leukemia-associated RhoGEF and Epidermal Growth Factor Receptor Promotes Rho/Ras Co-activation, Phospholipase C{epsilon}-Ca2+ Signaling, and Cytoskeleton Modification in Head and Neck Squamous Cell Carcinoma Cells J. Biol. Chem., May 19, 2006; 281(20): 14026 - 14040. [Abstract] [Full Text] [PDF]

				B. Salhia, F. Rutten, M. Nakada, C. Beaudry, M. Berens, A. Kwan, and J. T. Rutka Inhibition of Rho-Kinase Affects Astrocytoma Morphology, Motility, and Invasion through Activation of Rac1 Cancer Res., October 1, 2005; 65(19): 8792 - 8800. [Abstract] [Full Text] [PDF]

				C.-M. Wong, J. W.-P. Yam, Y.-P. Ching, T.-O. Yau, T. H.-Y. Leung, D.-Y. Jin, and I. O.-L. Ng Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma Cancer Res., October 1, 2005; 65(19): 8861 - 8868. [Abstract] [Full Text] [PDF]

				A. Hakem, O. Sanchez-Sweatman, A. You-Ten, G. Duncan, A. Wakeham, R. Khokha, and T. W. Mak RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis Genes & Dev., September 1, 2005; 19(17): 1974 - 1979. [Abstract] [Full Text] [PDF]

				Y.-W. Qiang, K. Walsh, L. Yao, N. Kedei, P. M. Blumberg, J. S. Rubin, J. Shaughnessy Jr, and S. Rudikoff Wnts induce migration and invasion of myeloma plasma cells Blood, September 1, 2005; 106(5): 1786 - 1793. [Abstract] [Full Text] [PDF]

				H. Nakagawa, K. Yoshioka, E. Miyahara, Y. Fukushima, M. Tamura, and K. Itoh Intrathecal Administration of Y-27632, a Specific Rho-Associated Kinase Inhibitor, for Rat Neoplastic Meningitis Mol. Cancer Res., August 1, 2005; 3(8): 425 - 433. [Abstract] [Full Text] [PDF]

				J.-Y. Lang, H. Chen, J. Zhou, Y.-X. Zhang, X.-W. Zhang, M.-H. Li, L.-P. Lin, J.-S. Zhang, M. P. Waalkes, and J. Ding Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway Clin. Cancer Res., May 1, 2005; 11(9): 3455 - 3464. [Abstract] [Full Text] [PDF]

				N. Liu, F. Bi, Y. Pan, L. Sun, Y. Xue, Y. Shi, X. Yao, Y. Zheng, and D. Fan Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity Clin. Cancer Res., September 15, 2004; 10(18): 6239 - 6247. [Abstract] [Full Text] [PDF]

				L. G. Strauss, A. Dimitrakopoulou-Strauss, D. Koczan, L. Bernd, U. Haberkorn, V. Ewerbeck, and H.-J. Thiesen 18F-FDG Kinetics and Gene Expression in Giant Cell Tumors J. Nucl. Med., September 1, 2004; 45(9): 1528 - 1535. [Abstract] [Full Text] [PDF]

				H. Nakanishi, K. Yoshioka, S. Joyama, N. Araki, A. Myoui, S. Ishiguro, T. Ueda, H. Yoshikawa, and K. Itoh Interleukin-6/Soluble Interleukin-6 Receptor Signaling Attenuates Proliferation and Invasion, and Induces Morphological Changes of a Newly Established Pleomorphic Malignant Fibrous Histiocytoma Cell Line Am. J. Pathol., August 1, 2004; 165(2): 471 - 480. [Abstract] [Full Text] [PDF]

				T. Kamai, T. Yamanishi, H. Shirataki, K. Takagi, H. Asami, Y. Ito, and K.-I. Yoshida Overexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer Clin. Cancer Res., July 15, 2004; 10(14): 4799 - 4805. [Abstract] [Full Text] [PDF]

				W. G. Jiang, G. Watkins, J. Lane, G. H. Cunnick, A. Douglas-Jones, K. Mokbel, and R. E. Mansel Prognostic Value of Rho GTPases and Rho Guanine Nucleotide Dissociation Inhibitors in Human Breast Cancers Clin. Cancer Res., December 15, 2003; 9(17): 6432 - 6440. [Abstract] [Full Text] [PDF]

				L. Y. W. Bourguignon, P. A. Singleton, H. Zhu, and F. Diedrich Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression J. Biol. Chem., August 8, 2003; 278(32): 29420 - 29434. [Abstract] [Full Text] [PDF]

				T. Kamai, T. Tsujii, K. Arai, K. Takagi, H. Asami, Y. Ito, and H. Oshima Significant Association of Rho/ROCK Pathway with Invasion and Metastasis of Bladder Cancer Clin. Cancer Res., July 1, 2003; 9(7): 2632 - 2641. [Abstract] [Full Text] [PDF]

				K. Yoshioka, V. Foletta, O. Bernard, and K. Itoh A role for LIM kinase in cancer invasion PNAS, June 10, 2003; 100(12): 7247 - 7252. [Abstract] [Full Text] [PDF]

				J. C. Hodge, J. Bub, S. Kaul, A. Kajdacsy-Balla, and P. F. Lindholm Requirement of RhoA Activity for Increased Nuclear Factor {kappa}B Activity and PC-3 Human Prostate Cancer Cell Invasion Cancer Res., March 15, 2003; 63(6): 1359 - 1364. [Abstract] [Full Text] [PDF]

				A. V. SOMLYO, C. PHELPS, C. DIPIERRO, M. ETO, P. READ, M. BARRETT, J. J. GIBSON, M. C. BURNITZ, C. MYERS, and A. P. SOMLYO Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants FASEB J, February 1, 2003; 17(2): 223 - 234. [Abstract] [Full Text] [PDF]

				O. Kim, J. Yang, and Y. Qiu Selective Activation of Small GTPase RhoA by Tyrosine Kinase Etk through Its Pleckstrin Homology Domain J. Biol. Chem., August 9, 2002; 277(33): 30066 - 30071. [Abstract] [Full Text] [PDF]

				P. M. Ghosh, R. Bedolla, M. Mikhailova, and J. I. Kreisberg RhoA-dependent Murine Prostate Cancer Cell Proliferation and Apoptosis: Role of Protein Kinase C{zeta} Cancer Res., May 1, 2002; 62(9): 2630 - 2636. [Abstract] [Full Text] [PDF]

				C. Denoyelle, M. Vasse, M. Korner, Z. Mishal, F. Ganne, J.-P. Vannier, J. Soria, and C. Soria Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study Carcinogenesis, August 1, 2001; 22(8): 1139 - 1148. [Abstract] [Full Text] [PDF]

				T. Kusama, M. Mukai, T. Iwasaki, M. Tatsuta, Y. Matsumoto, H. Akedo, and H. Nakamura Inhibition of Epidermal Growth Factor-induced RhoA Translocation and Invasion of Human Pancreatic Cancer Cells by 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors Cancer Res., June 1, 2001; 61(12): 4885 - 4891. [Abstract] [Full Text] [PDF]

				W. Du and G. C. Prendergast Geranylgeranylated RhoB Mediates Suppression of Human Tumor Cell Growth by Farnesyltransferase Inhibitors Cancer Res., November 1, 1999; 59(21): 5492 - 5496. [Abstract] [Full Text] [PDF]